Avedro Raises $25M In VC Funding

Ophthalmologic device and pharmaceutical developerAvedrohas raised $25 million in Series C venture capital financing. The funding round was led bySCP VitalifeandAperture Venture Partners.

Jeff Dykanof SCP Vitalife will join the Avedro board of directors, whileEric Sillmanof Aperture Venture Partners will join as a board observer. The financing will help the company expand commercial operations of the Vedera and KXL Systems outside the U.S. and seek U.S. Food and Drug Administration clearance for the products.

Click here for the release fromBusiness Wire.